We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Eureka Genomics Launches a Novel Custom Genotyping Service
Product News

Eureka Genomics Launches a Novel Custom Genotyping Service

Eureka Genomics Launches a Novel Custom Genotyping Service
Product News

Eureka Genomics Launches a Novel Custom Genotyping Service


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Eureka Genomics Launches a Novel Custom Genotyping Service"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

This platform addresses the gap between traditional array technologies and multiplex PCR and is designed for the customized detection of hundreds of SNPs in thousands of samples using a single lane of an Illumina next generation sequencer. Instead of making large amounts of data on small numbers of sample, LDMA makes very focused data on a large number of samples.

According to EG, this service can be used very broadly and provides researchers with an affordable tool to validate the putative makers from GWA and other types of studies. This custom service utilizes the power of next generation sequencing data generation and EG's proprietary bioinformatics and can be applied to the detection of SNPs, CNV, presence/absence and methylation. It can be used with DNA or RNA, with model organisms, commercial organisms or exotic organisms, and with complete or incomplete genomes.

"With this new service, individual researchers can harness the cost effectiveness of next generation sequencers to produce massive amounts of data that is focused on their biological sequences and SNPs of interest over large numbers of samples," said Heather Koshinsky, CSO, Eureka Genomics. "Instead of spending resources on all the extra data that accompany traditional arrays and sequencing, with the LDMA service researchers can focus on their biomarkers of interest and move more quickly and cost effectively to understand their biological question or disease."

Advertisement